C71T
CANCELLED SECTION 71
07/31/2026
Back to search
Official data from USPTO
BRIGHTPLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BRIGHTPLEX
ST13
US500000079260990Class
5, 9, 42, 44
Filing
79260990
Registration
5958367
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
07/31/2026
Trademark type
Word
Nice classes
5, 9, 42, 44
Filing date
04/18/2019
Registration date
01/14/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/31/2026
Last transaction
07/31/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
PENDLETON, CAROLYN A
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Veracyte
HalioDx
Representatives
Timothy Dell Nichols Workman Nydegger
Technical classification
Nice Classes
Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in in vitro testingfor use in the clinical diagnosisprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition; chemical preparations for medical and pharmaceutical use for use in in vitro testingfor use in the clinical diagnosisprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition; biological reagents for medical use for providing diagnostic or identification information of biological systems; immunological reagents for medical use; biological reagents for medical diagnosis; medical diagnostic kits comprising biological markersreagents and medical tests for diagnostic purposesfor testing biological tissue samples; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis
Class 9
Recorded software for use in the clinical diagnosisprognosismonitoringprediction of response to treatment and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition
Class 42
Researchdevelopmenttechnical design and scientific testing services in the field of oncology; industrial analysis and research services in the field of oncology; clinical trial services for others; tests in laboratoriesanalysis of biological mechanisms of actionsbiomarkers and signatures for research in biology purposes; development of quality control testing methods for others; researchdevelopmenttechnical designtestingconsulting and analysis services in the field of immunology and oncology; research and development of antibodiestherapeutic productsvaccinesimmunotherapy treatments and diagnostic products; research services in the field of immune repertoire analysis and the genome; design and development of software in the field of biology
Class 44
Medical analysis servicesanalysis of tumorcancer or equivalent medical condition; medical assistance; health care services; medical therapeutic services; medical diagnosticsdiagnostics in the field of medicine; genetic and tissue analysis services for medical purposes; medical testing services for the detectionquantificationlocalization of proteins or cells on a section of biological tissue for the purposes of medical diagnosisanalyzing the immune contexture of a tumor
Publications
History of USPTO decisions and trademark events.
29 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/21/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/14/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/12/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/22/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/24/2020
FIMP
FINAL DISPOSITION PROCESSED
04/24/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/14/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/29/2019
PUBO
PUBLISHED FOR OPPOSITION
10/29/2019
GPNX
NOTIFICATION PROCESSED BY IB
10/26/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/09/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2019
ALIE
ASSIGNED TO LIE
09/17/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/11/2019
RFNP
REFUSAL PROCESSED BY IB
08/09/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/22/2019
RFRR
REFUSAL PROCESSED BY MPU
07/22/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/30/2019
CNRT
NON-FINAL ACTION WRITTEN
06/29/2019
DOCK
ASSIGNED TO EXAMINER
06/26/2019
MAFR
APPLICATION FILING RECEIPT MAILED
06/25/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/20/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/13/2019
Continuous trademark protection
Get notified about every new filing that threatens BRIGHTPLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.